• Focus Areas
    • Cause Selection
    • Global Health & Wellbeing
      • Effective Altruism Community Growth (Global Health and Wellbeing)
      • Farm Animal Welfare
      • Global Aid Policy
      • Global Health & Development
      • Scientific Research
      • South Asian Air Quality
    • Longtermism
      • Biosecurity & Pandemic Preparedness
      • Effective Altruism Community Growth (Longtermism)
      • Potential Risks from Advanced AI
    • Other Areas
      • Criminal Justice Reform
      • History of Philanthropy
      • Immigration Policy
      • Land Use Reform
      • Macroeconomic Stabilization Policy
  • Grants
  • Research & Updates
    • Research Reports
    • Blog Posts
    • Notable Lessons
    • In the News
  • About Us
    • Grantmaking Process
    • How to Apply for Funding
    • Team
    • Contact Us
    • Stay Updated
  • We’re hiring!
  • Focus Areas
    • Cause Selection
    • Global Health & Wellbeing
      • Effective Altruism Community Growth (Global Health and Wellbeing)
      • Farm Animal Welfare
      • Global Aid Policy
      • Global Health & Development
      • Scientific Research
      • South Asian Air Quality
    • Longtermism
      • Biosecurity & Pandemic Preparedness
      • Effective Altruism Community Growth (Longtermism)
      • Potential Risks from Advanced AI
    • Other Areas
      • Criminal Justice Reform
      • History of Philanthropy
      • Immigration Policy
      • Land Use Reform
      • Macroeconomic Stabilization Policy
  • Grants
  • Research & Updates
    • Research Reports
    • Blog Posts
    • Notable Lessons
    • In the News
  • About Us
    • Grantmaking Process
    • How to Apply for Funding
    • Team
    • Contact Us
    • Stay Updated
  • We’re hiring!

UC Davis — Research on Antiviral Drugs (Koen Van Rompay)

Visit Grantee Site
  • Focus Area: Scientific Research
  • Organization Name: UC Davis
  • Amount: $170,190

  • Award Date: March 2020

Table of Contents


    Grant Investigators: Chris Somerville and Heather Youngs

    This page was reviewed but not written by the grant investigators. UC Davis staff also reviewed this page prior to publication.


    Open Philanthropy recommended a grant of $170,190 to UC Davis to support a trial led by Koen Van Rompay of an HSP90 inhibitor as a possible treatment for Zika infections in rhesus macaque monkeys. The results of the trial could have implications for the use of HSP90 inhibitors as antiviral treatments in humans. This funding is part of our science team’s effort to explore chaperone inhibitors as broad spectrum, host-directed antiviral drugs.

    This falls within our work on scientific research, specifically within our interest in science supporting biosecurity and pandemic preparedness.

    The grant amount was updated in May 2022.

    Related Items

    • Scientific Research

      UC Davis — Malaria Gene Drive Feasibility Analysis (Greg Lanzaro) (2021)

      Grant investigator: Chris Somerville and Heather Youngs. This page was reviewed but not written by the grant investigators. UC Davis staff also reviewed this page prior to publication. Open Philanthropy...

      Read more
    • Scientific Research

      UC Davis — COVID-19 Antiviral Studies (Lark L. Coffey)

      Open Philanthropy recommended a grant of $100,642 to UC Davis to enable Associate Professor Lark L. Coffey to collaborate with researchers at Duke University and the Weill Cornell...

      Read more
    • Scientific Research

      UC Davis — Malaria Gene Drive Feasibility Analysis (Greg Lanzaro)

      Open Philanthropy recommended a grant of $1,500,000 over 18 months to UC Davis to support a preliminary feasibility analysis of a potential test of gene drives for malaria...

      Read more
    Back to Grants Database
    Open Philanthropy
    Open Philanthropy
    • Careers
    • Press Kit
    • Governance
    • Privacy Policy
    • Stay Updated
    Mailing Address
    Open Philanthropy
    182 Howard Street #225
    San Francisco, CA 94105
    Email
    [email protected]
    Media Inquiries
    [email protected]
    Anonymous Feedback
    Feedback Form

    © Open Philanthropy 2022 Except where otherwise noted, this work is licensed under a Creative Commons Attribution-Noncommercial 4.0 International License. If you'd like to translate this content into another language, please get in touch!